Two Sigma Investments’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-333,694
| Closed | -$868K | – | 4877 |
|
|
2025
Q4 | $868K | Buy |
333,694
+322,727
| +2,943% | +$650K | ﹤0.01% | 3028 |
|
|
2025
Q3 | $19.3K | Sell |
10,967
-21,288
| -66% | -$34.1K | ﹤0.01% | 3598 |
|
|
2025
Q2 | $44.8K | Buy |
+32,255
| New | +$42.1K | ﹤0.01% | 3074 |
|
|
2025
Q1 | – | Sell |
-13,467
| Closed | -$17.6K | – | 3452 |
|
|
2024
Q4 | $17.6K | Sell |
13,467
-41,348
| -75% | -$123K | ﹤0.01% | 3117 |
|
|
2024
Q3 | $189K | Sell |
54,815
-23,567
| -30% | -$77.6K | ﹤0.01% | 2806 |
|
|
2024
Q2 | $259K | Buy |
78,382
+11,629
| +17% | +$41.5K | ﹤0.01% | 2650 |
|
|
2024
Q1 | $314K | Buy |
66,753
+41,277
| +162% | +$264K | ﹤0.01% | 2542 |
|
|
2023
Q4 | $186K | Buy |
+25,476
| New | +$143K | ﹤0.01% | 2853 |
|
|
2023
Q1 | – | Sell |
-15,653
| Closed | -$230K | – | 3173 |
|
|
2022
Q4 | $230K | Buy |
+15,653
| New | +$234K | ﹤0.01% | 2345 |
|
|
2022
Q3 | – | Sell |
-33,400
| Closed | -$467K | – | 2770 |
|
|
2022
Q2 | $467K | Buy |
+33,400
| New | +$393K | ﹤0.01% | 1853 |
|
Two Sigma Investments's RPTX Position: Q1 2026 in Review
Two Sigma Investments sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 333,694 shares — an estimated $868K sold.
Two Sigma Investments first reported a position in RPTX in Q2 2022 and held it in 10 quarters. The position peaked at $868K in Q4 2025. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.
- Two Sigma Investments reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
- Two Sigma Investments sold 333,694 Repare Therapeutics shares in Q1 2026, an estimated $868K.
- Two Sigma Investments first reported a position in Repare Therapeutics in Q2 2022 and held it in 10 quarters.
- Two Sigma Investments's Repare Therapeutics position peaked at $868K in Q4 2025.
- 0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.